Last reviewed: November 2017
Last updated: November  2017

Summary

Definition

History and exam

Key diagnostic factors

  • hematuria (gross or microscopic)
  • dysuria

Risk factors

  • tobacco exposure
  • exposure to chemical carcinogens
  • age >55 years
  • pelvic radiation
  • systemic chemotherapy
  • diabetes mellitus, type 2
  • Schistosoma infection
  • male gender
  • chronic bladder inflammation
  • positive FHx

Diagnostic investigations

Investigations to consider

  • urine cytology
  • renal and bladder ultrasound
  • CT urogram
  • cystoscopy
  • intravenous urogram
  • CBC
  • chemistry profile (including alkaline phosphatase)
  • CXR
  • CT abdomen and pelvis
  • MRI abdomen and pelvis
  • MR urogram
  • bone scan
  • urinary markers
Full details

Treatment algorithm

Contributors

Authors VIEW ALL

Director

BCG Oncology

Clinical Professor

University of Arizona

Phoenix

AZ

Disclosures

DL is an author of a number of references cited in this monograph.

Dr Donald Lamm would like to gratefully acknowledge Dr Mary Heeley, the previous contributor to this monograph. MH declares that she has no competing interests.

Peer reviewers VIEW ALL

Consultant Urological Surgeon

Homerton University Hospital NHS Foundation Trust

London

UK

Disclosures

JM declares that he has no competing interests.

Consultant Urologist

North Hampshire Hospital

Basingstoke

UK

Disclosures

HM has received honoraria from GE Healthcare and Kyowa Kirin UK.

Clinical Instructor of Urology

The James Buchanan Brady Urologic Institute

The Johns Hopkins Medical Institutions

Baltimore

MD

Disclosures

TG declares that he has no competing interests.

Consultant Urological Surgeon

Honorary Senior Lecturer

Department of Urology

The Royal Free & University College Medical School

London

UK

Disclosures

AK declares that he has no competing interests.

Use of this content is subject to our disclaimer